Page 2517 - Williams Hematology ( PDFDrive )

2488 Index Index 2489

Reproductive system disorders Retinopathy, in sickle cell disease, 772 Ribozymes, 153
acute myelogenous leukemia treatment Retroviral vectors, 439 Ribulose-phosphate epimerase, 697
and, 1411 Reviparin, 2274t R-ICE regimen, for diffuse large B-cell
history of, 5–6 R-FCM regimen, for follicular lymphoma, lymphoma, 1629t, 1631
Hodgkin lymphoma treatment and, 1618 1647 Richter syndrome, 1542
testicular lymphoma, 1246, 1581–1582, RFLPs (restriction fragment length Ricin A chain, 345
1582f, 1634 polymorphisms), 2116 Rickettsial infections, 997, 2105–2106
Resolvins, 286 R-FND, for follicular lymphoma, 1649 Rifampin
Respiration, regulation by hypoxia, 504f RHAg, 2337, 2339, 2342 maternal ingestion of, effect on fetus and
Respiratory burst reactions, 1068f RHAMM, 266–267 newborn, 112t
Respiratory syncytial virus (RSV) infection, Rh-associated glycoprotein, 2332t for tuberculosis, 386
384, 386 Rh blood group, 2330, 2336 RIG-I (retinoic acid inducible gene I),
Respiratory tract. See also Pulmonary ABO-Rh compatibility guidelines, 2350t 300–301, 302f
disease/dysfunction antibodies, 2344t RIG-I-like helicase (RLH) pathway, 300–303
iron deficiency and bleeding in, 630 antigens, 2331t, 2333–2334t, 2336, 2337 Rigosertib, for myelodysplastic syndromes,
macrophages in, 1082–1083 autoantibody and, 2340 1361
Response to injury hypothesis, 2281 disease associations, 2331t Ring sideroblasts, 178, 465, 567, 624, 918,
Restenosis, 1975, 1975f, 2296–2297 frequency, 2333–2334t 1353. See also Sideroblastic
Restriction fragment length polymorphisms genetics, 2339 anemias
(RFLPs), 2116 membrane structures in, 2330f Rip1, 207, 207f
Reteplase, 403, 2313t nomenclature, 2336 RIPA (ristocetin-induced platelet
Reticular dysgenesis, 530t, 532, 993, 1214t serologic detection, 2348–2349 agglutination), 2173
Reticulocyte count, 14, 16 RHCE, 2339 RIPK4, 1711
Reticulocyte indices, 16 RHD, 850, 2339 RISC (RNA-induced silencing complex),
Reticulocytes, 21, 482t Rh-deficiency syndrome, 684 153
in autoimmune hemolytic anemia, 832 Rheumatoid arthritis Ristocetin, 1867, 2168
automated analysis, 14, 16 aplastic anemia in, 518 Ristocetin cofactor assay/activity, 2164t, 2173
birth, 465–466, 467f Epstein-Barr virus infection and, 1265 Ristocetin-induced platelet agglutination
hemoglobin content, 635 large granular lymphocytic leukemia and, (RIPA), 2173
iron deficiency and, 633 1565 Ristocetin-induced platelet aggregation test,
macro-, 467 lymphomas and, 1574 1988–1989
maturation, 466–467, 466f neutropenia and, 996 Ritonavir, 1249
pathology, 467 Rh hemolytic disease, 849–850, 851f, Rituximab, 344
precursor cell kinetics, 75t 852t, 856f. See also Alloimmune for acquired hemophilia A, 2186
release, 72, 72f hemolytic disease of the fetus and adverse effects, 343t, 344, 1250, 1519t,
RNA content, 14 newborn (HDFN) 1535–1536, 2005, 2256
in sickle cell disease, 764–765 Rh immunoglobulin (RhIg), 858–859 for antiphospholipid syndrome, 2245
stress, 482f, 505 Rh-negative, 2348 for aplastic anemia, 526
Reticulum cell sarcoma, 1569 Rh phenotype, 2340, 2341t, 2342 for atypical hemolytic uremic syndrome,
null
Retinal abnormalities, 2241 Rho family, 230, 237, 1444, 1882–1883 2261
Retinal hemorrhages, 8 RhoH/TTF, 1626 for autograft purging, 358
Retinoblastoma protein. See RB (Rb) proteins Rh-positive, 2348 for autoimmune hemolytic anemia, 838,
all-trans-Retinoic acid. See ATRA (all-trans- Rh proteins, 835 839
retinoic acid) Rh-RhAG proteins, 665 for autoimmune lymphoproliferative
Retinoic acid inducible gene I (RIG-I), Rh sensitization, 432 syndrome, 1224
300–301, 302f R-hyperCVAD regimen, for mantle cell for B-cell acute lymphoblastic leukemia,
Retinoic acid receptor (RAR), 169 lymphoma, 1657, 1657t, 1658t 1515
Retinoic acid-related orphan receptor γ Ribavirin, 386 for Burkitt lymphoma, 1676
(RORγt), 1181f, 1182 Riboflavin (vitamin B ), 652t, 793, 2388 for Castleman disease, 1249–1250
2
Retinoic acid syndrome (differentiation Riboflavin (vitamin B ) deficiency, 651–652 with CHOP. See R-CHOP regimen
2
syndrome), 1405 Ribonucleotide reductase, 582f for chronic lymphocytic leukemia,
Retinoic receptor α (RARα), 1714 Ribonucleotide reductase inhibitors, 325, 1535–1536, 1537
Retinoids, 335. See also ATRA (all-trans- 606t. See also Hydroxyurea for diffuse large B-cell lymphoma, 1628,
retinoic acid) Ribosephosphate isomerase, 692t, 697 1628t, 1629t, 1630, 1631
for lymphomatoid papulosis, 1689 Ribosomal RNA (rRNA), 147, 195 dose, 343t, 344
for mycosis fungoides, 1685–1686 Ribosomes, 147, 192, 195 with EPOCH. See R-EPOCH regimen

Kaushansky_index_p2393-2506.indd 2488 9/21/15 3:22 PM